Compliance With Antihypertensive Telmisartan Therapy
Information source: Bayer
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hypertension
Intervention: Telmisartan (Kinzal/Pritor, BAY68-9291) (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Bayer Official(s) and/or principal investigator(s):
Bayer Study Director, Study Director, Affiliation: Bayer
Overall contact:
Bayer Clinical Trials Contact, Email: clinical-trials-contact@bayerhealthcare.com
Summary
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on
the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and
to asses patients compliance to the therapy with Telmisartan in relation to use of
electronic therapy monitoring device.
Clinical Details
Official title: A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy
Study design: Cohort, Prospective
Primary outcome: Efficacy and safety of the treatment with telmisartan reported by the physician with regard to usage the HelpingHand device
Secondary outcome: Compliance with the treatment calculated on the basis of by HelpingHand and patients questionnaires
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age over 18
- Untreated or ineffectively treated arterial hypertension
Exclusion Criteria:
- Cholestatic disorders and severe hepatic failure
- Allergy to Telmisartan
- Pregnancy and lactation period
- Unwillingness to participate in the study
- Inability to use the drug reminder device
- Unwillingness to use the drug reminder device
Locations and Contacts
Bayer Clinical Trials Contact, Email: clinical-trials-contact@bayerhealthcare.com
Many locations, Poland; Recruiting
Many locations, Slovakia; Recruiting
Additional Information
Click here and search for drug information provided by the FDA Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product Click here to find results for studies related to marketed products
Starting date: April 2007
Ending date: October 2009
Last updated: September 23, 2009
|
